Literature DB >> 26140311

Effects of food on pharmacokinetics of immediate release oral formulations.

Konrad Heintze1, Winfried Fuchs1.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26140311      PMCID: PMC4631199          DOI: 10.1111/bcp.12712

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  4 in total

1.  A single-tablet fixed-dose combination of racemic ibuprofen/paracetamol in the management of moderate to severe postoperative dental pain in adult and adolescent patients: a multicenter, two-stage, randomized, double-blind, parallel-group, placebo-controlled, factorial study.

Authors:  Donald R Mehlisch; Sue Aspley; Stephen E Daniels; Kristin A Southerden; Kyle S Christensen
Journal:  Clin Ther       Date:  2010-06       Impact factor: 3.393

Review 2.  Faster, higher, stronger? Evidence for formulation and efficacy for ibuprofen in acute pain.

Authors:  Andrew R Moore; Sheena Derry; Sebastian Straube; Jocelyn Ireson-Paine; Phillip J Wiffen
Journal:  Pain       Date:  2013-08-19       Impact factor: 6.961

Review 3.  Caffeine as an analgesic adjuvant for acute pain in adults.

Authors:  Christopher J Derry; Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2014-12-11

Review 4.  Effects of food on pharmacokinetics of immediate release oral formulations of aspirin, dipyrone, paracetamol and NSAIDs - a systematic review.

Authors:  Robert Andrew Moore; Sheena Derry; Philip J Wiffen; Sebastian Straube
Journal:  Br J Clin Pharmacol       Date:  2015-07-06       Impact factor: 4.335

  4 in total
  2 in total

1.  Reply to 'Effects of food on pharmacokinetics of immediate release oral formulations'.

Authors:  R Andrew Moore; Sheena Derry; Philip J Wiffen; Sebastian Straube
Journal:  Br J Clin Pharmacol       Date:  2015-08-27       Impact factor: 4.335

2.  Pharmacokinetic Properties of Ibuprofen (IBU) From the Fixed-Dose Combination IBU/Caffeine (400/100 mg; FDC) in Comparison With 400 mg IBU as Acid or Lysinate Under Fasted and Fed Conditions-Data From 2 Single-Center, Single-Dose, Randomized Crossover Studies in Healthy Volunteers.

Authors:  Thomas Weiser; Cornelia Schepers; Tobias Mück; Robert Lange
Journal:  Clin Pharmacol Drug Dev       Date:  2019-03-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.